US stock screener
Every US-listed company we cover, ranked by what it reported to the SEC. Figures come from each company’s own filings (P/E and dividend yield combine SEC share counts and TTM results with a daily price snapshot). Click a column to sort, or open a company for its full statements with per-figure provenance.
All sectorsTechnologyFinancialsHealthcareConsumer DiscretionaryConsumer StaplesEnergyIndustrialsMaterialsUtilitiesReal EstateCommunication Services
558 companies in Healthcare · page 1 of 6
| Company | Sector | Market cap | Revenue (FY) | Rev growth | Net margin | ROE | P/E (TTM) | Div yield |
|---|---|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Healthcare | $1.97B | $0 | -100.0% | — | -47.4% | — | — |
| Artiva Biotherapeutics, Inc. (ARTV) | Healthcare | $486.9M | $0 | -100.0% | — | -76.3% | — | — |
| Barinthus Biotherapeutics plc. (BRNS) | Healthcare | $24.5M | $0 | -100.0% | — | -89.4% | — | — |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | Healthcare | $1.10B | $0 | -100.0% | — | -34.4% | — | — |
| Denali Therapeutics Inc. (DNLI) | Healthcare | $3.63B | $0 | — | — | -50.6% | — | — |
| Fulcrum Therapeutics, Inc. (FULC) | Healthcare | $246.5M | $0 | -100.0% | — | -21.5% | — | — |
| KIORA PHARMACEUTICALS INC (KPRX) | Healthcare | $11.1M | $0 | -100.0% | — | -67.2% | — | — |
| Lite Strategy, Inc. (LITS) | Healthcare | $35.0M | $0 | -100.0% | — | -94.2% | — | — |
| Revolution Medicines, Inc. (RVMD) | Healthcare | $40.13B | $0 | — | — | -69.3% | — | — |
| SPRUCE BIOSCIENCES, INC. (SPRB) | Healthcare | $119.8M | $0 | -100.0% | — | -91.7% | — | — |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | Healthcare | $316.8M | $0 | -100.0% | — | -63.4% | — | — |
| Connect Biopharma Holdings Ltd (CNTB) | Healthcare | $138.5M | $64,000 | -99.8% | — | -132.2% | — | — |
| Mereo BioPharma Group plc (MREO) | Healthcare | $49.5M | $500,000 | — | — | -102.4% | — | — |
| Silence Therapeutics plc (SLN) | Healthcare | $515.8M | $559,000 | -98.7% | — | -142.2% | — | — |
| Lipocine Inc. (LPCN) | Healthcare | $18.4M | $2.0M | -82.3% | — | -66.5% | — | — |
| CollPlant Biotechnologies Ltd (CLGN) | Healthcare | $5.9M | $2.4M | 360.4% | — | -188.9% | — | — |
| Cartesian Therapeutics, Inc. (RNAC) | Healthcare | $244.7M | $2.8M | -92.8% | — | — | — | — |
| Surrozen, Inc./DE (SRZN) | Healthcare | $255.0M | $3.5M | -67.4% | — | — | — | — |
| CRISPR Therapeutics AG (CRSP) | Healthcare | $4.63B | $3.5M | -90.6% | — | -30.3% | — | — |
| ProPhase Labs, Inc. (PRPH) | Healthcare | $840,972 | $4.3M | -35.8% | — | -420.3% | — | — |
| NewGenIvf Group Ltd (NIVF) | Healthcare | $4.2M | $4.7M | -13.0% | — | 38.0% | — | — |
| SCIENTIFIC INDUSTRIES INC (SCND) | Healthcare | $8.0M | $5.1M | 5.4% | -24.1% | -11.4% | — | — |
| DBV Technologies S.A. (DBVT) | Healthcare | $870.0M | $5.6M | 35.8% | — | -87.1% | — | — |
| KYNTRA BIO, INC. (KYNB) | Healthcare | $28.6M | $6.4M | -78.3% | — | — | 0.2 | — |
| FATE THERAPEUTICS INC (FATE) | Healthcare | $300.7M | $6.6M | -51.2% | — | -65.8% | — | — |
| Immunome Inc. (IMNM) | Healthcare | $2.53B | $6.9M | -23.2% | — | -33.5% | — | — |
| Whitehawk Therapeutics, Inc. (WHWK) | Healthcare | $192.4M | $7.1M | -72.5% | — | -15.1% | — | — |
| Adagene Inc. (ADAG) | Healthcare | $236.5M | $7.7M | 7332.8% | — | — | — | — |
| Aclaris Therapeutics, Inc. (ACRS) | Healthcare | $784.9M | $7.8M | -58.2% | — | -63.0% | — | — |
| Roivant Sciences Ltd. (ROIV) | Healthcare | $25.25B | $8.3M | -71.6% | — | -5.7% | — | — |
| Aspira Women's Health Inc. (AWHL) | Healthcare | $18.7M | $9.2M | 0.4% | — | — | — | — |
| CURIS INC (CRIS) | Healthcare | $9.1M | $9.4M | -13.4% | -80.3% | -138.8% | — | — |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Healthcare | $446.6M | $9.7M | -92.8% | — | -87.0% | — | — |
| Taysha Gene Therapies, Inc. (TSHA) | Healthcare | $1.71B | $9.8M | 17.3% | — | -44.1% | — | — |
| WORK Medical Technology Group LTD (WOK) | Healthcare | $4.8M | $9.8M | -14.4% | -10.9% | -5.1% | — | — |
| Janux Therapeutics, Inc. (JANX) | Healthcare | $991.6M | $10.0M | -5.6% | — | -11.9% | — | — |
| Zenas BioPharma, Inc. (ZBIO) | Healthcare | $1.78B | $10.0M | 100.0% | — | -156.0% | — | — |
| Alpha Cognition Inc. (ACOG) | Healthcare | $179.2M | $10.2M | — | — | -33.1% | — | — |
| TScan Therapeutics, Inc. (TCRX) | Healthcare | $58.7M | $10.3M | 266.7% | — | -105.4% | — | — |
| CRESCENT BIOPHARMA, INC. (CBIO) | Healthcare | $629.5M | $10.8M | — | — | -75.8% | — | — |
| Caribou Biosciences, Inc. (CRBU) | Healthcare | $164.6M | $11.2M | 11.7% | — | -121.2% | — | — |
| NEXGEL, INC. (NXGL) | Healthcare | $4.3M | $11.4M | 31.5% | -26.3% | -61.3% | — | — |
| LogicMark, Inc. (LGMK) | Healthcare | $643,327 | $11.4M | 15.4% | -65.4% | — | — | — |
| Jaguar Health, Inc. (JAGX) | Healthcare | $6.4M | $11.5M | -1.5% | — | — | — | — |
| Cardiff Lexington Corp (CDIX) | Healthcare | $8.4M | $11.5M | 39.5% | -47.7% | — | — | — |
| ESCALON MEDICAL CORP (ESMC) | Healthcare | $1.5M | $12.0M | 0.5% | 0.9% | 5.5% | 1.8 | — |
| Prelude Therapeutics Inc (PRLD) | Healthcare | $334.5M | $12.1M | 73.4% | — | -145.0% | — | — |
| ELUTIA INC. (ELUT) | Healthcare | $41.2M | $12.3M | -15.0% | — | 192.9% | — | — |
| Emmaus Life Sciences, Inc. (EMMA) | Healthcare | $824,010 | $12.5M | -25.2% | -60.2% | — | — | — |
| Evommune, Inc. (EVMN) | Healthcare | $437.3M | $13.0M | 85.7% | — | -33.5% | — | — |
| Nano-X Imaging Ltd. (NNOX) | Healthcare | $78.0M | $13.0M | 15.4% | — | -53.7% | — | — |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | Healthcare | $198.1M | $13.1M | 29.8% | — | -50.6% | — | — |
| CapsoVision, Inc (CV) | Healthcare | $329.8M | $13.6M | 15.3% | — | -190.9% | — | — |
| Hyperfine, Inc. (HYPR) | Healthcare | $92.4M | $13.6M | 5.2% | — | -86.8% | — | — |
| Lineage Cell Therapeutics, Inc. (LCTX) | Healthcare | $289.2M | $13.6M | 67.0% | — | -146.6% | — | — |
| CV Sciences, Inc. (CVSI) | Healthcare | $4.1M | $13.8M | -12.2% | -6.9% | -65.3% | — | — |
| Pyxis Oncology, Inc. (PYXS) | Healthcare | $169.8M | $13.9M | -14.2% | — | -149.1% | — | — |
| Arbutus Biopharma Corp (ABUS) | Healthcare | $855.3M | $14.1M | 128.2% | — | -43.7% | 5.2 | — |
| Opus Genetics, Inc. (IRD) | Healthcare | $241.1M | $14.2M | 29.1% | — | -323.1% | — | — |
| VSEE HEALTH, INC. (VSEE) | Healthcare | $4.7M | $14.6M | 40.3% | — | -269.8% | — | — |
| ALLURION TECHNOLOGIES, INC. (ALUR) | Healthcare | — | $15.2M | -52.6% | — | — | — | — |
| Relay Therapeutics, Inc. (RLAY) | Healthcare | $4.22B | $15.4M | 53.4% | — | -48.8% | — | — |
| Neuphoria Therapeutics Inc. (NEUP) | Healthcare | $18.5M | $15.6M | — | -2.4% | -1.9% | — | — |
| BIOTRICITY INC. (BTCY) | Healthcare | $2.3M | $16.0M | 16.0% | -15.0% | — | — | — |
| Profound Medical Corp. (PROF) | Healthcare | $248.9M | $16.1M | 65.3% | — | -64.1% | 5.5 | — |
| uniQure N.V. (QURE) | Healthcare | $2.71B | $16.1M | -40.6% | — | -100.0% | — | — |
| FOXO TECHNOLOGIES INC. (FOXO) | Healthcare | $156,260 | $16.4M | 304.0% | -75.9% | -112.2% | — | — |
| Seer, Inc. (SEER) | Healthcare | $118.8M | $16.6M | 17.0% | — | -28.4% | — | — |
| Zhengye Biotechnology Holding Ltd (ZYBT) | Healthcare | $35.8M | $16.6M | -34.8% | -60.0% | -22.8% | — | — |
| Pelthos Therapeutics Inc. (PTHS) | Healthcare | $98.7M | $16.8M | — | — | -111.4% | — | — |
| Vivos Therapeutics, Inc. (VVOS) | Healthcare | $5.7M | $17.4M | 16.0% | — | — | — | — |
| Birchtech Corp. (BCHT) | Healthcare | $39.7M | $17.6M | 1.3% | -17.2% | — | — | — |
| Universe Pharmaceuticals INC (UPC) | Healthcare | $2.7M | $17.9M | -22.4% | -20.6% | -6.5% | — | — |
| Marpai, Inc. (MRAI) | Healthcare | $55.4M | $18.1M | -35.8% | -91.5% | — | — | — |
| OmniAb, Inc. (OABIW) | Healthcare | — | $18.7M | -29.3% | — | -24.3% | — | — |
| Bon Natural Life Ltd (BON) | Healthcare | $12.2M | $18.7M | -21.7% | -10.7% | -3.4% | — | — |
| NEPHROS INC (NEPH) | Healthcare | $40.9M | $18.8M | 32.7% | 6.4% | 11.7% | — | — |
| QT IMAGING HOLDINGS, INC. (QTI) | Healthcare | $38.6M | $18.9M | 287.9% | — | -327.1% | — | — |
| LENZ Therapeutics, Inc. (LENZ) | Healthcare | $158.3M | $19.1M | — | — | -28.9% | — | — |
| PRECISION OPTICS CORPORATION, INC. (POCI) | Healthcare | $47.1M | $19.1M | -0.1% | -30.3% | -47.2% | — | — |
| Sol-Gel Technologies Ltd. (SLGL) | Healthcare | $255.2M | $19.4M | 68.0% | -31.6% | -26.9% | — | — |
| Sonoma Pharmaceuticals, Inc. (SNOA) | Healthcare | $5.8M | $19.5M | 36.7% | -16.3% | -102.6% | — | — |
| Spectral AI, Inc. (MDAI) | Healthcare | $52.2M | $19.6M | -33.6% | -38.5% | — | — | — |
| Evofem Biosciences, Inc. (EVFM) | Healthcare | $1.1M | $20.2M | 4.2% | 1.9% | — | — | — |
| SCYNEXIS INC (SCYX) | Healthcare | $39.3M | $20.6M | 449.9% | -41.8% | -17.4% | — | — |
| Jin Medical International Ltd. (ZJYL) | Healthcare | $14.9M | $20.7M | -12.0% | 5.8% | 4.0% | — | — |
| CASI Pharmaceuticals, Inc. (CASIF) | Healthcare | $2.7M | $20.7M | -27.4% | — | — | — | — |
| Charlie's Holdings, Inc. (CHUC) | Healthcare | $47.7M | $20.9M | 169.4% | 21.5% | 131.4% | — | — |
| Alector, Inc. (ALEC) | Healthcare | $171.0M | $21.0M | -79.1% | — | -466.3% | — | — |
| Lifeward Ltd. (LFWD) | Healthcare | $19.8M | $22.0M | -14.1% | -90.4% | -236.8% | — | — |
| DarioHealth Corp. (DRIO) | Healthcare | $54.6M | $22.4M | -17.3% | — | -61.4% | 1.4 | — |
| NewAmsterdam Pharma Co N.V. (NAMS) | Healthcare | $3.57B | $22.5M | -50.6% | — | -29.8% | — | — |
| Baird Medical Investment Holdings Ltd (BDMD) | Healthcare | $33.6M | $22.5M | -39.2% | — | -87.4% | — | — |
| Precipio, Inc. (PRPO) | Healthcare | $40.9M | $24.0M | 29.8% | -1.5% | -2.5% | — | — |
| ALUMIS INC. (ALMS) | Healthcare | $3.67B | $24.1M | — | — | -80.8% | — | — |
| CYANOTECH CORP (CYAN) | Healthcare | $3.8M | $24.2M | 5.0% | -13.2% | -36.1% | — | — |
| Metagenomi Therapeutics, Inc. (MGX) | Healthcare | $45.9M | $25.2M | -51.8% | — | -55.4% | — | — |
| Entrada Therapeutics, Inc. (TRDA) | Healthcare | $234.9M | $25.4M | -87.9% | — | -47.0% | — | — |
| Celularity Inc (CELU) | Healthcare | $22.6M | $26.6M | -51.0% | — | — | — | — |
| Cue Biopharma, Inc. (CUE) | Healthcare | $143.7M | $27.5M | 195.7% | -96.9% | -100.6% | — | — |
Want more than a table?
Sign in to screen with custom filters (growth, ROIC, insider buying, short interest and 30+ more metrics), compare peers side by side, and get filing-grounded answers with citations. Free to start.
Start freeFundamentals from SEC EDGAR (public domain), as reported; valuation columns combine SEC filings with market data and are blanked where the two sources disagree. Informational only. Not investment advice.